Resident T Cell Activation Leads to Human Hair Follicle Immune Privilege Loss Ex Vivo, Prevented by DHODH Inhibitor Farudodstat: Relevance for Alopecia Areata

    April 2026 in “ Figshare
    Ilaria Piccini (33003), Thomas Rouillé, Wolfgang Funk (405807), Francisco Jimenez (8017871), Alexandre Kaoukhov, C. Firth, Amos Gilhar (359650), Janin Edelkamp, Ferda Cevikbas, Marta Bertolini (564966)
    Image of study
    TLDR Farudodstat can prevent hair follicle immune damage linked to alopecia areata.
    This study investigates the role of hair follicle (HF) resident T cells in the immune privilege (IP) collapse associated with alopecia areata (AA). Using a human HF organ culture model, researchers activated resident T cells with αCD3/αCD28 antibodies, leading to increased T cell proliferation and signs of IP collapse, such as elevated MHC class I and II expression. The study further explored the effects of the DHODH inhibitor farudodstat, which, when administered prior to and during T cell activation, reduced T cell proliferation and prevented IP collapse. These findings suggest that while T cell activation can induce an AA-like phenotype in healthy HFs, farudodstat can mitigate these effects, highlighting its potential relevance for AA treatment.
    Discuss this study in the Community →